Healthcare & Life Sciences Transactions
Overview
Navigating transactions in the healthcare and life sciences industry can be extraordinarily complex. Our attorneys have vast institutional knowledge and extensive experience counseling clients in the industry’s dynamic and distinct sectors, including pharmaceutical, biotechnology, medical devices, healthcare services and healthcare technology. With comprehensive involvement through all stages of the business life cycle, Kirkland attorneys are able to analyze matters from all perspectives and guide clients through the intricate issues unique to healthcare and life sciences in complex transactions, including M&A, financing, carve-outs, collaborations and joint ventures, among others.
Our renowned platform brings together best-in-class lawyers across the spectrum of practice areas that are essential to healthcare and life sciences transactions, including M&A, regulatory, finance, tax, antitrust, intellectual property and executive compensation. We pride ourselves on working together as an integrated, multidisciplinary team to provide seamless service to our global clients.
Public Company News and Insights - Healthcare & Life Sciences
Private Equity News and Insights - Healthcare & Life Sciences
150+ Healthcare & Life Sciences Transactions
Bloomberg, 2022–2023
~$100B Total Value of Healthcare & Life Sciences Transactions
Bloomberg, 2022–2023
2023 Healthcare Private Equity Outlook and Considerations
Kirkland Alert